In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

Santoro, Matteo; Maetzler, Walter; Stathakos, Petros; Martin, Heather L.; Hobert, Markus A.; Rattay, Tim W.; Gasser, Thomas; Forrester, John V.; Berg, Daniela; Tracey, Kevin J.; Riedel, Gernot; Teismann, Peter

dc.contributor.author	Maetzler, Walter
dc.contributor.author	Hobert, Markus Alexander
dc.contributor.author	Gasser, Thomas
dc.contributor.author	Berg, Daniela
dc.contributor.author	Rattay, Tim Wilfried
dc.date.accessioned	2016-11-08T10:42:11Z
dc.date.available	2016-11-08T10:42:11Z
dc.date.issued	2016
dc.identifier.issn	1095-953X
dc.identifier.uri	http://hdl.handle.net/10900/73094
dc.language.iso	en	de_DE
dc.publisher	Academic Press Inc Elsevier Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.nbd.2016.02.018	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_00343
utue.publikation.seiten	59-68	de_DE
utue.personen.roh	Santoro, Matteo
utue.personen.roh	Maetzler, Walter
utue.personen.roh	Stathakos, Petros
utue.personen.roh	Martin, Heather L.
utue.personen.roh	Hobert, Markus A.
utue.personen.roh	Rattay, Tim W.
utue.personen.roh	Gasser, Thomas
utue.personen.roh	Forrester, John V.
utue.personen.roh	Berg, Daniela
utue.personen.roh	Tracey, Kevin J.
utue.personen.roh	Riedel, Gernot
utue.personen.roh	Teismann, Peter
dcterms.isPartOf.ZSTitelID	Neurobiology of Disease	de_DE
dcterms.isPartOf.ZS-Volume	91	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE